Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.5900
+0.0440 (8.06%)
Aug 15, 2025, 12:44 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
Life-transforming Therapies
636.00K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
636.00K